GemPharmatech
Nanjing
About GemPharmatech
GemPharmatech is a high-tech biotechnology enterprise specializing in the research and development of humanized models and drug screening technologies. It has a leading disease model research and development ability and a genetic engineering mouse model creation center.In 2018, the company's "Humanization Model and Drug Screening Innovation Technology Research Institute" was absorbed by the Jiangsu Industrial Technology Research Institute as a "professional research institute", and became a new research and development institution that supports the establishment of an industrial chain and international development in this field. The company aims to provide global partners with one-stop innovative technologies and resource services such as model creation, breeding, mouse sales, phenotypic analysis, and functional efficacy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $50K – $100K
- Total funding: $23.3M
- Funding stage: IPO
- Last round: Series A (Jul 2019)
- Ticker: sse:688046
- Website: gempharmatech.com
- Phone: 025-58641580
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/gempharmatech-7023 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.